Arnaud Jacquel
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy.
Journal: Autophagy
Published: January 22, 2026
CSF1R regulates monocyte subset differentiation and intracellular metabolism.
Journal: bioRxiv : the preprint server for biology
Published: August 08, 2025
CSF1R regulates monocyte subset differentiation and intracellular metabolism.
Journal: Nature communications
Published: July 16, 2025
Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis.
Journal: Experimental hematology & oncology
Published: July 09, 2025
Dasatinib overcomes AML cells resistant to BCL2 inhibition by degrading MCL1.
Journal: British journal of haematology
Published: December 21, 2024
VEXAS, Chediak-Higashi syndrome and Danon disease: myeloid cell endo-lysosomal pathway dysfunction as a common denominator?
Journal: Cellular & molecular biology letters
Published: December 07, 2024
Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness.
Journal: Nature communications
Published: November 29, 2024
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells.
Journal: EMBO reports
Published: July 05, 2024
Emerging role of glutathione peroxidase 4 in myeloid cell lineage development and acute myeloid leukemia.
Journal: Cellular & molecular biology letters
Published: April 16, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 13, 2023
Last Updated: 09/26/2026